RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+8.09%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$5.5B
AUM Growth
+$5.5B
(-10%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-18.33%
Top 10 Holdings %
Top 10 Hldgs %
60.19%
Holding
79
New
13
Increased
18
Reduced
10
Closed
10
Top Buys
| 1 |
New Fortress Energy
NFE
|
$227M |
| 2 |
QuidelOrtho
QDEL
|
$60.1M |
| 3 |
Integra LifeSciences
IART
|
$52.7M |
| 4 |
Golar LNG
GLNG
|
$49.7M |
| 5 |
Delta Air Lines
DAL
|
$49M |
Top Sells
| 1 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$1.06B |
| 2 |
Vistra
VST
|
$252M |
| 3 |
Fluor
FLR
|
$71.9M |
| 4 |
Pediatrix Medical
MD
|
$67.3M |
| 5 |
PTVE
Pactiv Evergreen Inc. Common stock
PTVE
|
$65.9M |
Sector Composition
| 1 | Healthcare | 40.29% |
| 2 | Utilities | 26.19% |
| 3 | Energy | 11.3% |
| 4 | Technology | 5.94% |
| 5 | Financials | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLN
1
Talen Energy Corporation Common Stock
TLN
$17.3B
| $1.23B | 15.83% | 6,123,500 -5,245,114 | -46% | -$1.06B |
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $375M | 4.81% | 17,000,000 +994,502 | +6% | +$21.9M |
|
|
3
Golar LNG
GLNG
$4.48B
| $326M | 4.19% | 7,710,211 +1,175,149 | +18% | +$49.7M |
|
4
Viatris
VTRS
$12.3B
| $251M | 3.22% | 20,144,365 | – | – |
|
|
5
QuidelOrtho
QDEL
$1.95B
| $247M | 3.17% | 5,550,000 +1,350,000 | +32% | +$60.1M |
|
6
Roivant Sciences
ROIV
$8.15B
| $237M | 3.04% | 20,000,000 -2,400,000 | -11% | -$28.4M |
|
|
7
New Fortress Energy
NFE
$675M
| $227M | 2.91% | +15,000,000 | New | +$227M |
|
8
BGC Group
BGC
$4.65B
| $154M | 1.97% | 16,976,380 +3,800 | +0% | +$34.4K |
|
9
Arcutis Biotherapeutics
ARQT
$1.86B
| $153M | 1.96% | 10,966,672 | – | – |
|
10
TransAlta
TAC
$3.65B
| $108M | 1.38% | 7,612,663 +1,989,702 | +35% | +$28.2M |
|
11
Mr. Cooper
COOP
$12.1B
| $103M | 1.32% | 1,067,680 +31,682 | +3% | +$3.04M |
|
12
ReNew
RNW
$2.76B
| $99.2M | 1.27% | 14,527,412 +821,310 | +6% | +$5.61M |
|
13
United Airlines
UAL
$34B
| $96.7M | 1.24% | 995,759 -116,864 | -11% | -$11.3M |
|
14
Schrodinger
SDGR
$1.44B
| $96.5M | 1.24% | 5,000,000 +1,314,497 | +36% | +$25.4M |
|
15
Adaptive Biotechnologies
ADPT
$2.01B
| $87.5M | 1.12% | 14,600,000 +200,000 | +1% | +$1.2M |
|
16
Amneal Pharmaceuticals
AMRX
$3B
| $84.9M | 1.09% | 10,721,778 | – | – |
|
17
Liberty Global Class A
LBTYA
$4B
| $84.2M | 1.08% | 6,595,439 +1,064,538 | +19% | +$13.6M |
|
18
Alight
ALIT
$2.05B
| $80.6M | 1.03% | 11,646,679 | – | – |
|
19
Opko Health
OPK
$1.1B
| $71.6M | 0.92% | 48,706,640 | – | – |
|
20
Dole
DOLE
$1.4B
| $70.4M | 0.9% | 5,200,000 +58,612 | +1% | +$794K |
|
21
Collegium Pharmaceutical
COLL
$1.22B
| $67.3M | 0.86% | 2,350,000 +1,100,000 | +88% | +$31.5M |
|
|
22
Fluor
FLR
$6.63B
| $65.3M | 0.84% | 1,325,000 -1,458,441 | -52% | -$71.9M |
|
23
Adeia
ADEA
$1.64B
| $64.9M | 0.83% | 4,640,009 | – | – |
|
24
Orthofix Medical
OFIX
$592M
| $64.5M | 0.83% | 3,694,946 | – | – |
|
|
25
Integra LifeSciences
IART
$1.18B
| $59.4M | 0.76% | 2,618,341 +2,325,258 | +793% | +$52.7M |
|